438 related articles for article (PubMed ID: 12461611)
1. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
2. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
7. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
[TBL] [Abstract][Full Text] [Related]
9. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma.
Xia W; Lau YK; Hu MC; Li L; Johnston DA; Sheng Sj; El-Naggar A; Hung MC
Oncogene; 2000 May; 19(20):2398-403. PubMed ID: 10828881
[TBL] [Abstract][Full Text] [Related]
10. Maspin expression in oral squamous cell carcinoma.
Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
[TBL] [Abstract][Full Text] [Related]
11. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
12. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.
Basyuk E; Coulon V; Le Digarcher A; Coisy-Quivy M; Moles JP; Gandarillas A; Journot L
Mol Cancer Res; 2005 Sep; 3(9):483-92. PubMed ID: 16179495
[TBL] [Abstract][Full Text] [Related]
13. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas.
Moussali H; Bylaite M; Welss T; Abts HF; Ruzicka T; Walz M
Exp Dermatol; 2005 Jun; 14(6):420-8. PubMed ID: 15885077
[TBL] [Abstract][Full Text] [Related]
14. The expression of p63 in basal cell carcinomas and association with histological differentiation.
Bircan S; Candir O; Kapucoglu N; Baspinar S
J Cutan Pathol; 2006 Apr; 33(4):293-8. PubMed ID: 16630179
[TBL] [Abstract][Full Text] [Related]
15. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
[TBL] [Abstract][Full Text] [Related]
16. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions.
Reinisch CM; Uthman A; Erovic BM; Pammer J
J Cutan Pathol; 2007 Feb; 34(2):174-80. PubMed ID: 17244030
[TBL] [Abstract][Full Text] [Related]
17. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
[TBL] [Abstract][Full Text] [Related]
18. Maspin expression in myoepithelial tumors of the breast.
Reis-Filho JS; Milanezi F; Silva P; Schmitt FC
Pathol Res Pract; 2001; 197(12):817-21. PubMed ID: 11795829
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]